Ossio, Smith+Nephew shake up leadership teams & more: 8 device company notes

Eric Oliver -   Print  |

Here are eight key notes on spine and orthopedic device companies: 

Axis Spine received $1 million (830,000 pounds) from three investors as it readies to advance its anterior spinal implant technology in the U.S.

The FDA granted TDi 510(k) clearance for its SonoVision ultrasound system for spine surgery April 14.

Medicrea reported its full-year 2019 and first-quarter 2020 financial results, posting a $17 million (15.6 million euro) loss on the year. Read more

Biotechnology company CytoDyn appointed Scott Kelly, MD, as CMO and head of business development April 13.

Orthopedic fixation company Ossio recently added former Johnson & Johnson executive Gary Pruden to its board of directors.

Zimmer Biomet scaled back operations for two weeks due to the COVID-19 pandemic. 

Orthofix temporarily reduced the salaries of its U.S. employees, with the largest cuts being implemented at the executive and board levels.

Smith+Nephew named Anne-Francoise Nesmes CFO to oversee the company's finances.

More articles on spine: 
GI group expected to sign on to medical office building — 4 insights
Fujifilm receives CE mark for AI polyp detection tool
8 things to know about GI and ASCs in 2020

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers